Corcept Therapeutics Inc

NASDAQ:CORT   4:00:00 PM EDT
25.19
-0.13 (-0.51%)
6:16:23 PM EDT: $24.12 -1.07 (-4.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.61B
Current PE24.57
Forward PE 23.11
2yr Forward PE 18.25
See more stats
Estimates Current Quarter
Revenue$140.79 Million
Adjusted EPS$0.23
See more estimates
10-Day MA$24.65
50-Day MA$23.38
200-Day MA$26.42
See more pivots

Corcept Therapeutics Inc Stock, NASDAQ:CORT

149 Commonwealth Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.327.3270
Number of Employees: 352

Description

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.